Catherine Novack
Stock Analyst at Jones Trading
(2.55)
# 2,219
Out of 5,124 analysts
23
Total ratings
31.58%
Success rate
10.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SEPN Septerna | Initiates: Buy | $43 | $27.90 | +54.12% | 1 | Dec 23, 2025 | |
| KRRO Korro Bio | Downgrades: Hold | n/a | $8.01 | - | 2 | Nov 14, 2025 | |
| AARD Aardvark Therapeutics | Initiates: Buy | $33 | $13.13 | +151.43% | 1 | Oct 1, 2025 | |
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $19.56 | +53.37% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $28.86 | +0.49% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.58 | +941.31% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.69 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $104.67 | -57.01% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $2.02 | +444.55% | 1 | Feb 12, 2025 | |
| EQ Equillium | Downgrades: Hold | n/a | $1.55 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $17.00 | -5.88% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $3.81 | +267.45% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $1.93 | +573.58% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.36 | +323.73% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $6.59 | +233.84% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.30 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $0.66 | +24,234.60% | 1 | Jul 21, 2023 |
Septerna
Dec 23, 2025
Initiates: Buy
Price Target: $43
Current: $27.90
Upside: +54.12%
Korro Bio
Nov 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $8.01
Upside: -
Aardvark Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $33
Current: $13.13
Upside: +151.43%
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $19.56
Upside: +53.37%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $28.86
Upside: +0.49%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.58
Upside: +941.31%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.69
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $104.67
Upside: -57.01%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.02
Upside: +444.55%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.55
Upside: -
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $17.00
Upside: -5.88%
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.81
Upside: +267.45%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $1.93
Upside: +573.58%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $2.36
Upside: +323.73%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $6.59
Upside: +233.84%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.30
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $0.66
Upside: +24,234.60%